194 results on '"Paulussen, M"'
Search Results
2. Kolposkopische Befunde bei Verdacht auf sexuelle Gewalt an Kindern: Daten der Medizinischen Kinderschutzambulanz einer deutschen Kinderklinik
3. Bildgebende Diagnostik bei Kindesmisshandlung: Anwendung bildgebender Verfahren bei Kindern unter zwei Jahren in einer medizinischen Kinderschutzabteilung
4. Monocular enucleation profoundly reduces secretogranin II expression in adult mouse visual cortex
5. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
6. Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
7. Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers
8. Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies
9. Operative Therapie primär maligner Knochentumoren
10. High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
11. Behandlungskonzept des Ewing-Tumors
12. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
13. 6.O.05 THE IMPACT OF POOR RESPONSE TO INDUCTION CHEMOTHERAPY ON OUTCOME IN LOCALIZED EMBRYONAL RHABDOMYOSARCOMA - A REPORT FROM THE CWS STUDY GROUP
14. 4.P.30 OFFSPRINGS OF PATIENTS AFTER TREATMENT FOR OSTEOSARCOMA. WHAT DO WE POSSIBLY HAVE TO EXPECT?
15. 1.P.04 MODERATE WEIGHT LOSS UNDER EWING SARCOMA TREATMENT DOES NOT IMPAIR OUTCOME IN PATIENTS FROM THE (EI)CESS TRIALS.
16. 1.O.04 AN UPFRONT SCORE FOR PRIMARY DISSEMINATED MULTIFOCAL EWING TUMOR PATIENTS PREDICTING OUTCOME - RESULTS FROM THE EURO-E.W.I.N.G. 99 TRIAL
17. 1.O.03 TNM STAGING IN EWING SARCOMAS: A MODEL FROM THE (EI)CESS/EE99 STUDIES
18. 1.O.06 IS INSTITUTION A PROGNOSTIC FACTOR IN ADOLESCENT AND YOUNG ADULT PATIENTS WITH OSTEOSARCOMA?
19. Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
20. Prognostic implication of immunodetection of P glycoprotein in Ewing's sarcoma
21. EXTRAPULMONARY METASTATIC EWING TUMOR: GPOH STUDIES CESS 81 TO EICESS 92 SURVIVAL DATA: P.C.003
22. Successful HSCT following necrotising genital Pseudomonas cellulitis/ecthyma gangraenosum complicating intensification chemotherapy for acute leukaemia
23. Successful strategy for secondary antifungal prophylaxis in adolescents with acute leukaemia undergoing allogeneic stem cell transplantation
24. Safety, tolerance and plasma concentrations of voriconazole in immunocompromised paediatric patients
25. Relapse after High-Dose Therapy in Relapsed Ewingʼs Tumor Patients: Effects of Maintenance Chemotherapy in Two Selected Patients?
26. The course of fibrinolytic proteins in children with malignant bone tumours
27. Second malignancies after Ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study
28. Localized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86
29. Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group
30. Factors associated with tumor volume and primary metastases in Ewing tumors: Results from the (EI)CESS studies
31. Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study).
32. Ewing Sarcoma of the Hand or Foot: A Retrospective Analysis of 80 Patients Treated According to the Clinical Trial EICESS-92 and EURO-E.W.I.N.G.99.
33. Results of the EICESS-92 study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
34. Ewing tumours: outcome in children, adolescents and adult patients.
35. Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcoma.
36. Telemedizin in der P�diatrischen Onkologie.
37. Ewing Tumour: Incidence, Prognosis and Treatment Options.
38. Prognostic impact of tumor perfusion in MR-imaging studies in Ewing tumors.
39. Hochdosistherapie bei prim�r metastasiertem und rezidiviertem Ewing-Sarkom.
40. EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study) - Erste Ergebnisse.
41. Deskriptive Epidemiologie der Ewing-Tumoren - Analysen der deutschen Patienten von (EI) CESS 1980-1997*.
42. Lokaltherapie beim Ewing-Sarkom: Radiotherapeutische Aspekte.
43. Behandlungsergebnisse beim prim�r ausschlie�lich pulmonal metastasierten Ewingsarkom.
44. 4105 Is institution a prognostic factor in adolescent and young adult patients with osteosarcoma?b
45. Hemithorax irradition in Ewing tumors of the chest wall
46. Ewing tumor as second malignancy—the EI(CESS)-experience
47. Second primary cancer after Ewing tumours - experience in 690 patients from a cooperative treatment study
48. Missing ligand model in autologous stem cell transplantation.
49. A patient with two Ewing's sarcomas with distinct EWS fusion transcripts.
50. Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.